Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2002-09-25
2008-03-18
Foley, Shanon (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S069100, C435S325000
Reexamination Certificate
active
07345156
ABSTRACT:
Genes up-regulated in hepatocellular carcinomas and polypeptides encoded by these genes are provided. Vectors, transformants and methods for producing the recombinant polypeptides are also provided. Probes and primers of these genes and antibodies against the polypeptides are also provided. The probes, primers and antibodies can be used as reagents for detecting hepatocellular carcinomas. Methods for detecting hepatocellular carcinomas using such detection reagents are further provided. Antisense nucleolide sequences of these genes are also provided and can be used to inhibit growth of hepatocellular carcinomas.
REFERENCES:
patent: 6783961 (2004-08-01), Edwards et al.
patent: WO 99/39200 (1999-08-01), None
patent: WO 00/17355 (2000-03-01), None
patent: WO 00/44900 (2000-08-01), None
patent: WO 03/027143 (2003-04-01), None
patent: WO 03/027143 (2003-04-01), None
patent: WO 03/027322 (2003-04-01), None
patent: WO 03/027322 (2003-04-01), None
UniProt 7.2 data base.
Carninci et al., Genome research, vol. 10, 1617-1630, 2000.
Database, N-Geneseq-200701, accession No. AAA08583.
EST database Accession No. BE747972 , Sep. 15, 2000.
Edwards et al., EP 1033401A2, date of publication, Sep. 6, 2000.
Verma et al., Nature, 1997, vol. 389, pp. 239-242.
Eck et al., Gene-Based Therapy, In: The Pharmacological Basis of Therapeutics, Goodman and Gilman, Ed.s, 1996, pp. 77-101.
Orkin et al., Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy, NIH, 1995.
Ansieau, et al.,J. Biol. Chem., 277(7):4906-4910 (2002).
Aratani, et al.,Mol. Cell. Biol., 21(14):4460-4469 (2001).
Brummelkamp, et al.,Science, 296(5567):550-553 (2002).
Cerione, et al.,Curr. Opin. Cell Biol., 8(2):216-222 (1996).
Chardin, et al.,Nature, 384(6608):481-484 (1996).
Choi, et al.,Cancer, 79(10):1879-1883 (1997).
Cukierman, et al.,Science, 270(5244):1999-2002 (1995).
Database EMBL Accession No. AK000206, Feb. 22, 2000.
Database EMBL Accession No. BG773806, May 16, 2001.
Delwel, et al.,Mol. Cell. Biol., 13(7):4291-4300 (1993).
Elbashir, et al.,Nature, 411(6836):494-498 (2001).
EMBL Accession No. AL557360, Feb. 11, 2001.
Fu, et al.,J. Virol., 67(12):6965-6972 (1993).
Gelmetti, et al.,Mol. Cell. Biol., 8(12):7185-7191 (1998).
Ghanem, et al.,Cancer, 92(12):3120-3129 (2001).
Golub, et al.,Science, 286(5439):531-537 (1999).
Gross, et al.,EMBO J., 15(8):1961-1870 (1996).
Hamamoto, et al.,Proceedings of the Am. Assoc. for Cancer Res. Annual, 43:13(#63), and English translation, (2002).
Hamamoto, et al.,94thAnnual Mtg. Of the Am. Assoc. for Cancer Res., 44:54(#236), and English translation, (2003).
Hamamoto, et al.,94thAnnual Mtg. Of the Am. Assoc. for Cancer Res., 44(Second Edition):47(#236), and English translation, (2003).
Hamamoto, et al.,Jpn. J. Cancer Res., 92(Supplement):117(#208), and English translation, (2001).
Hamamoto, et al.,Jpn. J. Cancer Res., 93(Supplement):78(#2032), and English translation, (2002).
Hamamoto, et al.,Jpn. J. Cancer Res., 286(#3339-OP), and English translation, (2003).
Hamamoto, et al.,Jpn Assoc. Mol. Target Ther. Cancer, 36(#SY-1), and English translation, (2002).
Hammond, et al.,Nature, 404(6775):293-296 (2000).
Hannon, et al.,Nature, 418(6894):244-251 (2002).
Herbst, et al.,Cancer, 94(5):1593-1611 (2002).
Hermouet, et al.,Proc. Natl. Acad. Sci. USA, 88(23):10455-10459 (1991).
Ito, et al.,Br. J. Cancer, 84(10):1377-1383 (2001).
Jackson, et al.,Trends Biochem. Sci., 25(10):489-495 (2000).
Kato, et al.,Jpn. J. Cancer Res., 93(Supplement):78(2033), and English translation, (2002).
Kibar, et al.,Nat. Genet., 28(3):251-255 (2001).
Lüking, et al.,Crit. Rev. Biochem. Mol. Biol., 33(4):259-296 (1998).
Lutterbach, et al.,Mol. Cell. Biol., 18(12):7176-7184 (1998).
Lyons, et al.,Science, 249(4969):655-659 (1990).
Masselink, et al.,Oncogene, 19(12):1538-1546 (2000).
Mendelsohn, et al.,Oncogene, 19(56):6550-6565 (2000).
Miyagishi, et al.,Nat. Biotechnol., 19:497-500 (2002).
Miyaki, et al.,Int. J. Cancer, 85(4):518-522 (2000).
Mochizuki, et al.,Gene, 181(1-2):39-43 (1996).
Moss, et al.,J. Biol. Chem., 270(21):12327-12330 (1995).
Nakajima, et al.,Cell, 90(6):1107-1112 (1997).
Okabe, et al.,Cancer Res., 61(5):2129-2137 (2001).
Pace, et al.,Proc. Natl. Acad. Sci. USA, 88(16):7031-7035 (1991).
Perou, et al.,Nature, 406(6797):747-752 (200).
Randazzo, et al.,Proc. Natl. Acad. Sci. USA, 97(8):4011-4016 (2000).
Sharp, P.A.,Genes Dev., 13(2):139-141 (1999).
Tanaka, et al.,Biochim. Biophys. Acta, 1536(1):1-12 (2001).
Tang, et al.,Mol. Cell. Biol., 19(5):3540-3550 (1999).
Tanner, et al.,Mol. Cell, 8(2):251-262 (2001).
von Marschall, et al.,Gut, 48(1):87-96 (2001).
Westermarck, et al.,EMBO J., 21(3):451-460 (2002).
Wolff, et al.,Development, 125(6):1149-1159 (1998).
Yagyu, et al.,Jpn. J. Cancer Res., 92(Supplement):118(209), and English translation, (2001).
Yagyu, et al.,Int. J. Oncol., 20(6):1173-1178 (2002).
Ying, et al.,Biochem. Biophys. Res. Commun., 286(2):394-400 (2001).
EMBL Accession No. AK024733, Sep. 29, 2000.
Furukawa Yoichi
Nakamura Yusuke
Beattie Ingrid A.
Foley Shanon
Kozakiewicz Cynthia A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Oncotherapy Science, Incorporated
LandOfFree
Hepatocellular carcinoma-related genes and polypeptides, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatocellular carcinoma-related genes and polypeptides, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatocellular carcinoma-related genes and polypeptides, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3961814